Advertisement
Screener

Contineum Therapeutics, Inc. (CTNM) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Contineum Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Contineum Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $55.31M went out.
  • Fiscal year ended 2025-12-31: from investing, $3.71M went out.
  • Fiscal year ended 2025-12-31: from financing, $112.69M came in.
  • Fiscal year ended 2025-12-31: change in cash, $53.66M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$55.31M-$3.71M$219.00K$112.47M*$53.66M
2024-12-31-$32.84M-$69.74M$0.00$0.00$108.21M$790.00K*$6.42M
2023-12-31$19.35M-$65.57M-$28.00K-$3.75M$0.00$59.95M*$9.96M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$11.50M*$4.85M*$473.00K*$727.00K*
2026-03-31-$16.27M-$39.31M$198.00K-$55.45M
2025-12-31-$13.04M*-$47.45M*$22.00K*$93.44M*
2025-09-30-$12.20M*$14.94M*$173.00K*$18.93M*
2025-06-30-$15.66M*$13.88M*$0.00*
2025-03-31-$14.41M$14.91M$24.00K$527.00K
2024-12-31-$10.20M*-$9.39M*$0.00*$257.00K*
2024-09-30-$6.17M*-$30.18M*$0.00*$13.00K*
2024-06-30-$8.50M*-$38.90M*$0.00*$13.00K*$108.35M*
2024-03-31-$7.97M$8.73M$0.00$122.00K$738.00K
2023-12-31-$10.70M*$9.03M*$0.00*$0.00*
2023-09-30-$5.38M*-$39.50M*$0.00*$0.00*$10.32M*
2023-06-30$40.67M*-$44.46M*-$3.13M*$19.00K*$49.90M*
2023-03-31-$5.24M$9.36M-$625.00K$8.00K$3.49M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Mereo BioPharma Group plc (MREO)$0.269B-9.41
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02